Lucite Commemorating Drug Approval and Launch

Custom Lucite commemorating the launch of a generic version of Clobazam tablets and oral suspension, for the treatment of seizures associated with Lennox-Gastaut syndrome. FDA approval was received for these two versions in October, 2018.